SAKAR HEALTHCARE
Back to Balance Sheet
|
SAKAR HEALTHCARE Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹2.66 Cr | ₹2.29 Cr | ₹1.70 Cr | ₹1.44 Cr | ₹0.79 Cr |
What is the latest Long Term Provisions ratio of SAKAR HEALTHCARE ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹2.66 Cr |
| Mar2024 | ₹2.29 Cr |
| Mar2023 | ₹1.70 Cr |
| Mar2022 | ₹1.44 Cr |
| Mar2021 | ₹0.79 Cr |
How is Long Term Provisions of SAKAR HEALTHCARE Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹2.66 Cr | 16.26 | |
| Mar2024 | ₹2.29 Cr | 34.75 | |
| Mar2023 | ₹1.70 Cr | 18.08 | |
| Mar2022 | ₹1.44 Cr | 81.34 | |
| Mar2021 | ₹0.79 Cr | - | |
Compare Long Term Provisions of peers of SAKAR HEALTHCARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAKAR HEALTHCARE | ₹2,426.6 Cr | -3.2% | 26.6% | 205% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹436,679.0 Cr | -1.8% | -7% | 14.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,408.0 Cr | -3.4% | 0.4% | 58.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹182,634.0 Cr | -2.7% | -3.6% | 36% | Stock Analytics | |
| CIPLA | ₹109,063.0 Cr | -3.9% | -4.7% | -10.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,166.0 Cr | 3% | 6.1% | -3.8% | Stock Analytics | |
SAKAR HEALTHCARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAKAR HEALTHCARE | -3.2% |
26.6% |
205% |
| SENSEX | -3.1% |
-6.2% |
-11.7% |
You may also like the below Video Courses